Heterometallic titanium–gold complexes inhibit renal cancer cells in vitro and in vivoJacob Fernández‐Gallardo(The Graduate Center, CUNY), Marı́a Contel(City University of New York)Chemical ScienceJanuary 1, 201510.1039/c5sc01753jCited by 121SaveCiteExport RISWatch citationsRelated PapersUnconventional Anticancer Metallodrugs and Strategies to Improve their Pharmacological Profile|Unknown|2019|0